Laboratory-confirmed Cholera and Rotavirus Among Patients with Acute Diarrhea in Four Hospitals in Haiti, 2012-2013

Overview

Journal Am J Trop Med Hyg

Specialty Tropical Medicine

Date 2013 Oct 10

PMID 24106190

Citations 17

Authors

Maria W Steenland

Gerard A Joseph

Mentor Ali Ber Lucien

Nicole Freeman

Marisa Hast

Benjamin L Nygren

Eyal Leshem

Stanley Juin

Michele B Parsons

Deborah F Talkington

Eric D Mintz

John Vertefeuille

S Arunmozhi Balajee

Jacques Boncy

Mark A Katz

Affiliations

Soon will be listed here.

Abstract

An outbreak of cholera began in Haiti in October of 2010. To understand the progression of epidemic cholera in Haiti, in April of 2012, we initiated laboratory-enhanced surveillance for diarrheal disease in four Haitian hospitals in three departments. At each site, we sampled up to 10 hospitalized patients each week with acute watery diarrhea. We tested 1,616 specimens collected from April 2, 2012 to March 28, 2013; 1,030 (63.7%) specimens yielded Vibrio cholerae, 13 (0.8%) specimens yielded Shigella, 6 (0.4%) specimens yielded Salmonella, and 63 (3.9%) specimens tested positive for rotavirus. Additionally, 13.5% of children < 5 years old tested positive for rotavirus. Of 1,030 V. cholerae isolates, 1,020 (99.0%) isolates were serotype Ogawa, 9 (0.9%) isolates were serotype Inaba, and 1 isolate was non-toxigenic V. cholerae O139. During 1 year of surveillance, toxigenic cholera continued to be the main cause of acute diarrhea in hospitalized patients, and rotavirus was an important cause of diarrhea-related hospitalizations in children.

Citing Articles

Estimating the proportion of clinically suspected cholera cases that are true Vibrio cholerae infections: A systematic review and meta-analysis.

Wiens K, Xu H, Zou K, Mwaba J, Lessler J, Malembaka E PLoS Med. 2023; 20(9):e1004286.

PMID: 37708235 PMC: 10538743. DOI: 10.1371/journal.pmed.1004286.

Effectiveness of monovalent rotavirus vaccine against hospitalizations due to all rotavirus and equine-like G3P[8] genotypes in Haiti 2014-2019.

Burnett E, Juin S, Esona M, Desormeaux A, Aliabadi N, Pierre M Vaccine. 2021; 39(32):4458-4462.

PMID: 34187708 PMC: 8474148. DOI: 10.1016/j.vaccine.2021.06.055.

Epidemiological and molecular forensics of cholera recurrence in Haiti.

Rebaudet S, Moore S, Rossignol E, Bogreau H, Gaudart J, Normand A Sci Rep. 2019; 9(1):1164.

PMID: 30718586 PMC: 6361935. DOI: 10.1038/s41598-018-37706-0.

Risk Factors for Self-Reported Cholera Within HIV-Affected Households in Rural Haiti.

Richterman A, Cheung H, Meiselbach M, Jerome G, Ternier R, Ivers L Open Forum Infect Dis. 2018; 5(6):ofy127.

PMID: 29942825 PMC: 6007289. DOI: 10.1093/ofid/ofy127.

Laboratory evaluation of immunochromatographic rapid diagnostic tests for cholera in Haiti.

Matias W, Julceus F, Abelard C, Mayo-Smith L, Franke M, Harris J PLoS One. 2017; 12(11):e0186710.

PMID: 29091945 PMC: 5665506. DOI: 10.1371/journal.pone.0186710.

References

Siddique A, Ahmed S, Iqbal A, Sobhan A, Poddar G, Azim T . Epidemiology of rotavirus and cholera in children aged less than five years in rural Bangladesh. J Health Popul Nutr. 2011; 29(1):1-8. PMC: 3075054. DOI: 10.3329/jhpn.v29i1.7560. View

Chowdhury F, Rahman M, Begum Y, Khan A, Faruque A, Saha N . Impact of rapid urbanization on the rates of infection by Vibrio cholerae O1 and enterotoxigenic Escherichia coli in Dhaka, Bangladesh. PLoS Negl Trop Dis. 2011; 5(4):e999. PMC: 3071362. DOI: 10.1371/journal.pntd.0000999. View

Hasan N, Choi S, Eppinger M, Clark P, Chen A, Alam M . Genomic diversity of 2010 Haitian cholera outbreak strains. Proc Natl Acad Sci U S A. 2012; 109(29):E2010-7. PMC: 3406840. DOI: 10.1073/pnas.1207359109. View

Boncy J, Rossignol E, Dahourou G, Hast M, Buteau J, Stanislas M . Performance and utility of a rapid diagnostic test for cholera: notes from Haiti. Diagn Microbiol Infect Dis. 2013; 76(4):521-3. DOI: 10.1016/j.diagmicrobio.2013.03.010. View

Manna B, Niyogi S, Bhattacharya M, Sur D, Bhattacharya S . Observations from diarrhoea surveillance support the use of cholera vaccination in endemic areas. Int J Infect Dis. 2005; 9(2):117-9. DOI: 10.1016/j.ijid.2004.06.008. View

De Oliveira L, Danovaro-Holliday M, Andrus J, de Fillipis A, Gentsch J, Ruiz Matus C . Sentinel hospital surveillance for rotavirus in latin american and Caribbean countries. J Infect Dis. 2009; 200 Suppl 1:S131-9. DOI: 10.1086/605060. View

Tappero J, Tauxe R . Lessons learned during public health response to cholera epidemic in Haiti and the Dominican Republic. Emerg Infect Dis. 2011; 17(11):2087-93. PMC: 3310587. DOI: 10.3201/eid1711.110827. View

Pascual M, Bouma M, Dobson A . Cholera and climate: revisiting the quantitative evidence. Microbes Infect. 2002; 4(2):237-45. DOI: 10.1016/s1286-4579(01)01533-7. View

Katz L, Petkau A, Beaulaurier J, Tyler S, Antonova E, Turnsek M . Evolutionary dynamics of Vibrio cholerae O1 following a single-source introduction to Haiti. mBio. 2013; 4(4). PMC: 3705451. DOI: 10.1128/mBio.00398-13. View

10.

Fields P, Popovic T, Wachsmuth K, Olsvik O . Use of polymerase chain reaction for detection of toxigenic Vibrio cholerae O1 strains from the Latin American cholera epidemic. J Clin Microbiol. 1992; 30(8):2118-21. PMC: 265454. DOI: 10.1128/jcm.30.8.2118-2121.1992. View

11.

Jorgensen J, Hindler J . New consensus guidelines from the Clinical and Laboratory Standards Institute for antimicrobial susceptibility testing of infrequently isolated or fastidious bacteria. Clin Infect Dis. 2006; 44(2):280-6. DOI: 10.1086/510431. View

12.

Patel M, Pitzer V, Alonso W, Vera D, Lopman B, Tate J . Global seasonality of rotavirus disease. Pediatr Infect Dis J. 2012; 32(4):e134-47. PMC: 4103797. DOI: 10.1097/INF.0b013e31827d3b68. View

13.

Talkington D, Bopp C, Tarr C, Parsons M, Dahourou G, Freeman M . Characterization of toxigenic Vibrio cholerae from Haiti, 2010-2011. Emerg Infect Dis. 2011; 17(11):2122-9. PMC: 3310580. DOI: 10.3201/eid1711.110805. View

14.

. Notes from the field: Identification of Vibrio cholerae serogroup O1, serotype Inaba, biotype El Tor strain - Haiti, March 2012. MMWR Morb Mortal Wkly Rep. 2012; 61(17):309. View

15.

Page A, Alberti K, Mondonge V, Rauzier J, Quilici M, Guerin P . Evaluation of a rapid test for the diagnosis of cholera in the absence of a gold standard. PLoS One. 2012; 7(5):e37360. PMC: 3364251. DOI: 10.1371/journal.pone.0037360. View

16.

Boyce T, Mintz E, Greene K, Wells J, Hockin J, Morgan D . Vibrio cholerae O139 Bengal infections among tourists to Southeast Asia: an intercontinental foodborne outbreak. J Infect Dis. 1995; 172(5):1401-4. DOI: 10.1093/infdis/172.5.1401. View

17.

Mukherjee P, Ghosh S, Ramamurthy T, Bhattacharya M, Nandy R, Takeda Y . Evaluation of a rapid immunochromatographic dipstick kit for diagnosis of cholera emphasizes its outbreak utility. Jpn J Infect Dis. 2010; 63(4):234-8. View

18.

Sur D, Deen J, Manna B, Niyogi S, Deb A, Kanungo S . The burden of cholera in the slums of Kolkata, India: data from a prospective, community based study. Arch Dis Child. 2005; 90(11):1175-81. PMC: 1720149. DOI: 10.1136/adc.2004.071316. View

19.

Ley B, Khatib A, Thriemer K, von Seidlein L, Deen J, Mukhopadyay A . Evaluation of a rapid dipstick (Crystal VC) for the diagnosis of cholera in Zanzibar and a comparison with previous studies. PLoS One. 2012; 7(5):e36930. PMC: 3360732. DOI: 10.1371/journal.pone.0036930. View

20.

Barzilay E, Schaad N, Magloire R, Mung K, Boncy J, Dahourou G . Cholera surveillance during the Haiti epidemic--the first 2 years. N Engl J Med. 2013; 368(7):599-609. DOI: 10.1056/NEJMoa1204927. View